Overview

Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)

Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Combination of guanfacine with opioid medication as a standard treatment for chronic pain.
Phase:
N/A
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
Treatments:
Guanfacine
Polystyrene sulfonic acid